During the past decade, Irccs Multimedica Santa Maria; Unita' Di Neurologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Irccs Multimedica Santa Maria; Unita' Di Neurologia" are "Alzheimer's Disease" (3 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Irccs Multimedica Santa Maria; Unita' Di Neurologia" in a lesser frequency.

Most popular intervention types in "Irccs Multimedica Santa Maria; Unita' Di Neurologia" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (3 trials), "Placebo" (3 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Irccs Multimedica Santa Maria; Unita' Di Neurologia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Irccs Multimedica Santa Maria; Unita' Di Neurologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Irccs Multimedica Santa Maria; Unita' Di Neurologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Irccs Multimedica Santa Maria; Unita' Di Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".